Hydrofarm Holdings (HYFM) Stock Analysis — October 2026
Executive Summary
Hydrofarm Holdings (NASDAQ: HYFM) is a ancillary cannabis company currently priced at $0.80 per share with a market capitalization of $3.8M. The stock trades on the NASDAQ exchange in the United States market, and is positioned as a small-cap player within the cannabis sector.
Key Takeaways
Hydrofarm Holdings has a market cap of $3.8M, making it a small-cap cannabis company listed on the NASDAQ.
Hydrofarm Holdings holds $6.6M in cash against $114.5M in debt, resulting in a net debt position of $107.8M.
At $0.80, the stock trades at 11% of its 52-week range ($0.50 – $3.20). Trading near yearly lows could present value for contrarian investors.
Hydrofarm Holdings Company Overview
Hydrofarm Holdings (NASDAQ: HYFM) is an ancillary cannabis company currently trading at $0.80 per share with a market capitalization of $3.8M. The stock gained +7.06% in the most recent trading session on volume of 84.0K shares. Hydrofarm Holdings is headquartered in the United States and employs approximately 286 people. As a participant in the ancillary cannabis segment, the company operates within one of the most dynamic and rapidly evolving sectors of the North American economy.
Trailing twelve-month (TTM) revenue for Hydrofarm Holdings is not reported in our data. Revenue trends in the cannabis industry are closely watched by analysts, as the sector continues to navigate pricing compression, oversupply dynamics in certain markets, and the ongoing burden of IRS Section 280E, which prevents cannabis businesses from deducting ordinary business expenses at the federal level.
Financial Analysis
Trailing twelve-month revenue for Hydrofarm Holdings is not reported in our data.
Revenue momentum is a critical metric for cannabis companies, as the industry continues to evolve through shifts in consumer demand, regulatory changes, and competitive dynamics. Year-over-year revenue growth for Hydrofarm Holdings is not reported in our data. The cannabis industry's profitability dynamics are heavily influenced by IRS Section 280E, which prevents plant-touching operators from deducting ordinary business expenses for federal income tax purposes, effectively creating tax rates that can exceed 70% of gross profit.
Valuation Analysis
A price-to-sales (P/S) ratio for Hydrofarm Holdings is not available in our data. Cannabis stock valuations have compressed significantly from their 2021 highs, and current multiples reflect a more mature market environment where investors demand clear paths to profitability. For context, the broader Ancillary sector contains 5 publicly traded companies tracked by Cannabismarketcap, and Hydrofarm Holdings's valuation should be considered within the context of its specific growth profile and competitive positioning.
Today, Hydrofarm Holdings's valuation reflects the market's current assessment of the company's growth potential and risk profile. Enterprise value — calculated as market capitalization plus total debt minus cash — stands at approximately $111.6M, providing a more complete picture of the company's total valuation when accounting for balance sheet items. Investors should compare these multiples against both direct sector peers and historical ranges to determine whether HYFM is trading at a premium or discount.
Balance Sheet Deep Dive
Hydrofarm Holdings carries net debt of $107.8M, with $114.5M in total debt against $6.6M in cash and equivalents. Access to capital remains a persistent challenge for cannabis companies, particularly plant-touching operators that are excluded from traditional banking services and institutional lending. Many cannabis companies have turned to sale-leaseback transactions, private placements, and at-the-market (ATM) equity offerings to fund operations. Hydrofarm Holdings's balance sheet should be evaluated with these industry-specific constraints in mind.
Hydrofarm Holdings carries a net debt position of $107.8M, with $114.5M in total debt exceeding $6.6M in cash and equivalents. Investors should monitor the company's ability to service its debt obligations, improve operational cash flow, and potentially refinance existing obligations at favorable terms. In the cannabis industry, where access to traditional banking remains restricted, balance sheet strength is a critical differentiator.
The company's annual share dilution rate is not reported in our data. With 4.8M shares currently outstanding, any additional equity issuance directly impacts per-share metrics including earnings per share, book value per share, and ownership percentage.
Ancillary Cannabis Sector Context
Within the Ancillary Cannabis sector, Hydrofarm Holdings ranks #5 out of 5 companies by market capitalization, commanding a 0.1% share of the sector's total market cap of $4.89B. Ancillary cannabis companies provide products and services that support the cannabis industry without directly touching the plant. This includes hydroponics suppliers, packaging companies, technology platforms, consulting firms, and real estate services. The largest company in the sector by market cap is Scotts Miracle-Gro (SMG) at $3.45B, followed by Turning Point Brands (TPB) at $1.31B.
Trailing twelve-month revenue for Hydrofarm Holdings is not reported in our data, so it is not ranked by revenue. The sector's top revenue generator is Scotts Miracle-Gro at $3.48B.
Hydrofarm Holdings occupies a smaller position within the Ancillary Cannabis sector. The company's market capitalization of $3.8M reflects the market's assessment of its growth potential and risk profile relative to the 4 other tracked peers. Investors should evaluate Hydrofarm Holdings alongside its direct sector competitors to understand relative value and operational momentum.
Historical Price Performance
Hydrofarm Holdings (HYFM) currently trades at $0.80, which places the stock at approximately 11% of its 52-week trading range. Over the past twelve months, HYFM has traded as high as $3.20 and as low as $0.50, representing a 540.0% spread between the yearly high and low. The current price sits 75.2% below the 52-week high and 59.0% above the 52-week low. This range provides important context for understanding the stock's recent volatility and where current levels fall within the broader price history.
In the most recent trading session, HYFM rose +7.06% from a previous close of $0.74 to $0.80, on volume of 84.0K shares. This positive session represents a significant single-day move that may have been driven by company-specific news, sector-wide sentiment, or broader market dynamics. The stock has 4,819,323 shares outstanding, giving it a fully diluted market capitalization that investors should factor into their analysis alongside the current $3.8M market cap figure.
Cannabis stocks have historically exhibited significant price volatility driven by regulatory developments, earnings surprises, and shifts in market sentiment toward the sector. HYFM is trading in the lower portion of its 52-week range, which could represent a value opportunity for contrarian investors, or may reflect deteriorating fundamentals that warrant caution. Historical price levels should be considered alongside fundamental data — including revenue trends, margin improvement, and balance sheet health — to form a complete investment thesis.
Investment Thesis
A balanced framework for evaluating Hydrofarm Holdings (HYFM) as a potential investment, considering both the upside catalysts and downside risks based on the company's current financial data and industry positioning.
Revenue stabilization and potential for operational improvements could reignite top-line growth. Even modest gains in market share or pricing power could meaningfully impact the company's financial trajectory and investor sentiment toward HYFM.
Potential for margin recovery as the cannabis market matures and pricing stabilizes. Regulatory reform — particularly the rescheduling of cannabis and elimination of Section 280E tax burdens — could dramatically improve the gross margin profile for Hydrofarm Holdings and the broader industry.
Federal cannabis reform — including potential rescheduling, banking access via the SAFE Banking Act, or eventual descheduling — would be a transformative catalyst for Hydrofarm Holdings and the entire cannabis sector. Any legislative progress could unlock institutional capital flows, improve banking access, and eliminate the Section 280E tax burden that suppresses profitability industry-wide.
Intensifying competition from both legal operators and the persistent illicit market could pressure Hydrofarm Holdings's revenue growth and margins. The cannabis industry remains highly fragmented, and market share gains are becoming increasingly difficult as more states award licenses and new competitors enter the market.
Net debt position of $107.8M creates financing risk. The company may need to raise additional capital through dilutive equity offerings or high-cost debt, which would further pressure per-share value and increase financial risk.
Regulatory uncertainty remains the single largest risk for Hydrofarm Holdings and all cannabis investments. Federal prohibition in the United States creates ongoing challenges including Section 280E tax burdens, limited interstate commerce, and the risk of enforcement actions. State-level regulatory changes, licensing moratoriums, and social equity requirements add additional layers of unpredictability that can materially impact the company's operations and growth plans.
Risk Factors
Key risks that investors should consider before investing in Hydrofarm Holdings (HYFM). This is not an exhaustive list, and investors should conduct their own due diligence.
Regulatory & Legal Risk
Cannabis remains a Schedule I controlled substance under federal law, creating fundamental legal uncertainty for Hydrofarm Holdings and all plant-touching cannabis operators. Changes in federal enforcement policy, state regulatory frameworks, or local ordinances could materially impact the company's operations, licensing, and financial performance. The evolving patchwork of state regulations creates compliance complexity and limits the ability to operate across state lines.
Balance Sheet & Liquidity Risk
With $6.6M in cash against $114.5M in total debt, Hydrofarm Holdings faces potential liquidity constraints. The company may need to secure additional financing through equity raises (which dilute shareholders), debt issuance (which increases financial risk), or asset sales (which may reduce operational capacity). Cannabis companies' limited access to traditional banking further constrains available financing options.
Section 280E Tax Burden
Under IRS Section 280E, cannabis businesses are prohibited from deducting ordinary business expenses for federal income tax purposes. This effectively results in tax rates that can exceed 70% of gross profit for plant-touching operators, significantly reducing cash flow available for reinvestment and debt service. While potential rescheduling could eliminate this burden, the timeline and outcome remain uncertain, and Hydrofarm Holdings's profitability metrics should be evaluated with this tax overhang in mind.
Market & Competition Risk
The cannabis industry faces pricing pressure from oversupply in mature markets, competition from the illicit market (which avoids regulatory costs and taxation), and evolving consumer preferences. Hydrofarm Holdings competes for market share against both established operators and well-funded new entrants. Price compression in key markets has squeezed margins across the industry, and any worsening of these trends could materially impact the company's revenue and profitability outlook.
Frequently Asked Questions
Common questions about Hydrofarm Holdings (HYFM) stock, answered with real-time data from Cannabismarketcap.
What is Hydrofarm Holdings's (HYFM) stock price today?
Hydrofarm Holdings (HYFM) stock is currently trading at $0.80 per share on the NASDAQ exchange. This represents a daily gain of +7.06% ($0.0524) from the previous closing price of $0.74. Over the past 52 weeks, HYFM has traded between a low of $0.50 and a high of $3.20, placing the current price at approximately -75% from its annual high. The stock has a market capitalization of $3.8M, making it a notable cannabis-adjacent companies tracked by Cannabismarketcap. Hydrofarm Holdings operates in the Ancillary sector, classified under "WHOLESALE-MISCELLANEOUS NONDURABLE GOODS", serving the broader cannabis industry.
What is Hydrofarm Holdings's market capitalization?
Hydrofarm Holdings (HYFM) has a current market capitalization of $3.8M, calculated by multiplying its 4.8M shares outstanding by the current stock price of $0.80. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places Hydrofarm Holdings among the small-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $111.6M, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.
What are Hydrofarm Holdings's key financial metrics?
Hydrofarm Holdings (HYFM) reports several important financial metrics that investors track closely. The company has a market capitalization of $3.8M. Hydrofarm Holdings holds $6.6M in cash and equivalents against $114.5M in total debt. Total debt equals 30.26x market capitalization. With 4.8M shares outstanding, investors should consider both the fundamental financial performance and share structure when evaluating HYFM.
How many employees does Hydrofarm Holdings have?
Hydrofarm Holdings currently employs approximately 286 people across its operations. As an ancillary cannabis company headquartered in the United States, its workforce supports activities spanning wholesale-miscellaneous nondurable goods and related business functions. Employee count is an important indicator of a company's operational scale and its capacity for growth in an industry that remains highly labor-intensive due to regulatory requirements.
What exchange is HYFM listed on?
Hydrofarm Holdings trades under the ticker symbol HYFM on the NASDAQ exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts. The company has been publicly listed since 2020-12-10, giving it a track record in the public markets that investors can analyze for long-term trends. The stock sees average daily trading volume of approximately 84.0K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.
What sector is Hydrofarm Holdings in?
Hydrofarm Holdings is classified as an ancillary cannabis company, meaning it provides supporting products, services, or technology to the cannabis industry without directly handling the plant. Its official SIC classification is "WHOLESALE-MISCELLANEOUS NONDURABLE GOODS," which provides additional detail about its core business activities. The Ancillary sector is a key segment of the cannabis market, and investors often compare companies within the same sector to identify relative outperformers. You can compare HYFM with other Ancillary stocks on Cannabismarketcap's sector page to see how it ranks on metrics like market cap, revenue, and margins.
How does HYFM compare to other cannabis stocks?
You can compare Hydrofarm Holdings (HYFM) side-by-side with any cannabis stock on Cannabismarketcap using the dedicated comparison tool. Key comparison metrics include market cap ($3.8M). Hydrofarm Holdings sits in the Ancillary sector, so the most relevant peer comparisons would be against other Ancillary companies, though cross-sector comparisons can also reveal interesting insights about relative valuation. Visit the rankings page to see where HYFM stands across all cannabis companies on metrics like revenue growth, cash position ($6.6M), and employee count (286).
What is HYFM's 52-week trading range?
Hydrofarm Holdings (HYFM) has traded between a 52-week low of $0.50 and a 52-week high of $3.20, with the current price of $0.80 sitting approximately -75% from the annual high. This range represents a spread of $2.70 (540% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.
How does Hydrofarm Holdings's valuation compare to cannabis industry peers?
Hydrofarm Holdings (HYFM) is valued at a market capitalization of $3.8M, and an enterprise value of $111.6M. In the cannabis industry, valuations can vary significantly depending on sector (MSO, LP, Ancillary, etc.), growth rate, and path to profitability. Investors can use the Cannabismarketcap rankings and comparison tools to benchmark HYFM against specific competitors on valuation multiples, growth rates, and profitability.
What is Hydrofarm Holdings's enterprise value?
Hydrofarm Holdings (HYFM) has an estimated enterprise value (EV) of $111.6M, which is calculated by taking the market capitalization of $3.8M, adding total debt of $114.5M, and subtracting cash and equivalents of $6.6M. Enterprise value is widely considered a more comprehensive measure of a company's total value than market cap alone because it accounts for the capital structure, including debt obligations and available liquidity. For cannabis companies in particular, where balance sheet health varies dramatically, enterprise value provides a more accurate picture of acquisition cost and relative valuation.
Is Hydrofarm Holdings stock overvalued or undervalued?
Determining whether Hydrofarm Holdings (HYFM) is overvalued or undervalued requires analyzing multiple valuation metrics in context. The stock is currently trading at $0.80, which is -75% from its 52-week high of $3.20. Investors should consider the company's enterprise value of $111.6M, its cash position of $6.6M, and the broader cannabis industry outlook when forming a valuation opinion. Cannabismarketcap provides all the data needed for a thorough analysis, but this information should not be considered investment advice.
What are the risks of investing in Hydrofarm Holdings?
Investing in Hydrofarm Holdings (HYFM) carries several risks that investors should carefully consider. First, the cannabis industry remains federally illegal in the United States, creating regulatory uncertainty that can impact stock prices, banking access, and tax obligations (notably IRC Section 280E). Second, Hydrofarm Holdings's balance sheet shows $114.5M in total debt against $6.6M in cash, which investors should monitor for dilution risk or liquidity concerns. Additionally, the stock has shown a 52-week range of $0.50 to $3.20, reflecting meaningful price volatility. As with all cannabis stocks, investors face risks from changing state regulations, competitive pressures, and the evolving legal landscape. This information is for educational purposes only and is not investment advice.
What is Hydrofarm Holdings's cash position and debt level?
Hydrofarm Holdings (HYFM) holds $6.6M in cash and equivalents on its balance sheet, set against $114.5M in total debt. This gives the company a net debt position of $107.8M. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.
How many shares outstanding does Hydrofarm Holdings have?
Hydrofarm Holdings (HYFM) currently has 4.8M shares outstanding, which when multiplied by the current stock price of $0.80 gives the company its market capitalization of $3.8M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.
Does Hydrofarm Holdings pay a dividend?
Most cannabis companies, including Hydrofarm Holdings (HYFM), do not currently pay dividends. The cannabis industry is still in a growth phase, and companies typically reinvest available capital into expanding operations, securing new licenses, building out retail and cultivation infrastructure, and navigating complex regulatory requirements. Additionally, the IRC Section 280E tax burden significantly reduces the free cash flow available for shareholder distributions. Investors in cannabis stocks should generally expect returns to come from capital appreciation rather than dividend income. If Hydrofarm Holdings initiates a dividend in the future, it would be reported in their SEC filings and reflected on Cannabismarketcap.
How can I research Hydrofarm Holdings stock before investing?
To research Hydrofarm Holdings (HYFM) before investing, start with the company overview on Cannabismarketcap, which provides current price ($0.80), market cap ($3.8M), and key financial metrics. Next, review the full financial statements page for quarterly revenue trends, margins, and balance sheet details. Check the analyst ratings page for Wall Street consensus and price targets, and the technical analysis page for chart patterns and momentum indicators. Compare HYFM against sector peers using the comparison tool to understand relative valuation. Review recent news coverage for regulatory developments or corporate events. Finally, read the investment analysis page for a comprehensive deep-dive. Cannabis investing carries unique risks including federal illegality, regulatory uncertainty, and limited banking access — always conduct thorough due diligence before making any investment decision.
What does Hydrofarm Holdings's market cap of $3.8M mean?
Hydrofarm Holdings's market capitalization of $3.8M represents the total market value of all its outstanding shares (4.8M shares multiplied by the current stock price of $0.80). Market cap is the primary measure investors use to classify companies by size: small-cap companies (under $100M) like Hydrofarm Holdings may offer higher growth potential but come with greater risk and lower liquidity. In the cannabis sector, market cap is especially important because it determines index weighting, institutional investment eligibility, and often correlates with the company's operational scale and geographic reach. Hydrofarm Holdings currently ranks # among cannabis stocks tracked on Cannabismarketcap.
What regulatory risks does Hydrofarm Holdings face?
Hydrofarm Holdings (HYFM), like all cannabis companies, faces significant regulatory risks that investors should understand. At the federal level, cannabis remains a Schedule I controlled substance in the United States, which restricts banking access, prevents standard business expense deductions under IRC Section 280E, and creates legal uncertainty. Hydrofarm Holdings is subject to the evolving regulatory landscape across the jurisdictions where it operates. Potential catalysts include federal rescheduling (which could ease 280E burdens), the SAFE Banking Act (which would improve banking access), and individual state legalization events. Conversely, regulatory setbacks such as license moratoriums, increased enforcement, or unfavorable tax policy changes pose downside risks. Investors should monitor legislative developments closely using Cannabismarketcap's news and legalization tracker.
More HYFM Research & Data
HYFM price, chart & key stats
Revenue, earnings & balance sheet
Quarterly earnings & EPS trends
Historical price & volume chart
Step-by-step buying guide
Side-by-side peer comparison
Detailed investment thesis & outlook
Disclaimer: The information presented on this page is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other kind of advice. Cannabismarketcap does not recommend that any security be bought, sold, or held by you. All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. Cannabis stocks carry additional risks including federal illegality, regulatory uncertainty, limited banking access, and high volatility. Always conduct your own research and consider consulting a qualified financial advisor before making investment decisions.